Akhondzadeh S - Search Results

1

A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia.

Arbabi M, Bagheri M, Rezaei F, Ahmadi-Abhari SA, Tabrizi M, Khalighi-Sigaroudi F, Akhondzadeh S. Arbabi M, et al. Among authors: akhondzadeh s. Psychopharmacology (Berl). 2012 Apr;220(3):591-8. doi: 10.1007/s00213-011-2513-z. Epub 2011 Sep 24. Psychopharmacology (Berl). 2012. PMID: 21947320 Clinical Trial.

2

Combination of clomipramine and nortriptyline in the treatment of obsessive-compulsive disorder: a double-blind, placebo-controlled trial.

Noorbala AA, Hosseini SH, Mohammadi MR, Akhondzadeh S. Noorbala AA, et al. Among authors: akhondzadeh s. J Clin Pharm Ther. 1998 Apr;23(2):155-9. doi: 10.1046/j.1365-2710.1998.00156.x. J Clin Pharm Ther. 1998. PMID: 9786103 Clinical Trial.

3

Cyproheptadine in treatment of chronic schizophrenia: a double-blind, placebo-controlled study.

Akhondzadeh S, Mohammadi MR, Amini-Nooshabadi H, Davari-Ashtiani R. Akhondzadeh S, et al. J Clin Pharm Ther. 1999 Feb;24(1):49-52. doi: 10.1046/j.1365-2710.1999.00197.x. J Clin Pharm Ther. 1999. PMID: 10319907 Clinical Trial.

4

Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia.

Noorbala AA, Akhondzadeh S, Davari-Ashtiani R, Amini-Nooshabadi H. Noorbala AA, et al. Among authors: akhondzadeh s. J Clin Pharm Ther. 1999 Oct;24(5):369-74. doi: 10.1046/j.1365-2710.1999.00238.x. J Clin Pharm Ther. 1999. PMID: 10583700 Clinical Trial.

5

Is it time to have another look at lithium maintenance therapy in bipolar disorder?

Akhondzadeh S, Emamian ES, Ahmadi-Abhari A, Shabestari O, Dadgarnejad M. Akhondzadeh S, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1999 Aug;23(6):1011-7. doi: 10.1016/s0278-5846(99)00056-1. Prog Neuropsychopharmacol Biol Psychiatry. 1999. PMID: 10621946 Clinical Trial.

6

Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions.

Akhondzadeh S, Shasavand E, Jamilian H, Shabestari O, Kamalipour A. Akhondzadeh S, et al. J Clin Pharm Ther. 2000 Apr;25(2):131-7. doi: 10.1046/j.1365-2710.2000.00273.x. J Clin Pharm Ther. 2000. PMID: 10849191 Clinical Trial.

7

Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal.

Akhondzadeh S, Ahmadi-Abhari SA, Assadi SM, Shabestari OL, Kashani AR, Farzanehgan ZM. Akhondzadeh S, et al. J Clin Pharm Ther. 2000 Oct;25(5):347-53. doi: 10.1046/j.1365-2710.2000.00295.x. J Clin Pharm Ther. 2000. PMID: 11123486 Clinical Trial.

8

Baclofen versus clonidine in the treatment of opiates withdrawal, side-effects aspect: a double-blind randomized controlled trial.

Ahmadi-Abhari SA, Akhondzadeh S, Assadi SM, Shabestari OL, Farzanehgan ZM, Kamlipour A. Ahmadi-Abhari SA, et al. Among authors: akhondzadeh s. J Clin Pharm Ther. 2001 Feb;26(1):67-71. doi: 10.1046/j.1365-2710.2001.00325.x. J Clin Pharm Ther. 2001. PMID: 11286609 Clinical Trial.

9

Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial.

Akhondzadeh S, Kashani L, Mobaseri M, Hosseini SH, Nikzad S, Khani M. Akhondzadeh S, et al. J Clin Pharm Ther. 2001 Oct;26(5):369-73. doi: 10.1046/j.1365-2710.2001.00366.x. J Clin Pharm Ther. 2001. PMID: 11679027 Clinical Trial.

10

Diazoxide in the treatment of schizophrenia: novel application of potassium channel openers in the treatment of schizophrenia.

Akhondzadeh S, Mojtahedzadeh V, Mirsepassi GR, Moin M, Amini-Nooshabadi H, Kamalipour A. Akhondzadeh S, et al. J Clin Pharm Ther. 2002 Dec;27(6):453-9. doi: 10.1046/j.1365-2710.2002.00445.x. J Clin Pharm Ther. 2002. PMID: 12472985 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

403 results

Search Page

Filters